High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

Explore HIV prevention options for women, including dapivirine rings and dual prevention pills, aiming to reduce infections ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

7 October 2024 (Lima, Peru) – New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.

He says that three days after receiving the therapy, he felt his skin loosen ... more than a year after receiving the treatment. Researchers have therefore started creating CAR-T therapies from ...

Lenacapavir was approved by the FDA in December 2022 as an HIV treatment. It is given in combination with other antiretrovirals. Treatment begins with an injection and tablets followed by an injection ...

Since 2010, HIV-related deaths have been reduced by 51%, but HIV continues to be a major global public health issue, claiming 40.4 million lives so far. As effective therapy ... used in combination ...

and The Second Public Hospital in Jiulongpo (SPH)) provided antiretroviral therapy services for HIV/AIDS and authorized healthcare personnel inputted information of PLWH, including personal, treatment ...

The Centers for Disease Control and Prevention first used the term “AIDS” on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis ...